Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02293213 · ClinicalTrials.gov registry record · NA
EMR Referrals for Teratogen and Contraceptive Counseling for Category D or X Medication Users: RCT
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT02293213: Completed NA study, sponsored by University of California, San Diego.
NCT02293213 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 33 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02293213, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
Investigators propose a randomized controlled trial of women taking category D or X medications seen in family medicine, internal medicine or in the Coumadin Clinic. Women in the intervention group will receive an electronic medical record referral for teratogen counseling and contraceptive counseling with a follow up contraceptive provision appointment. The contraceptive counseling will be adapted from The Contraceptive CHOICE Project script and promote the use of the long acting reversible contraception. The women in the control group will also receive an electronic medical record referral and receive the teratogen counseling but only be told that it is important to avoid becoming pregnant. An initial survey will assess contraceptive knowledge and utilization. In addition, there will be telephone survey at 3 months and 6 months to assess contraceptive utilization and continuation.
Primary Outcome
Change of contraception from baseline questionnaire compared to 3 and 6 month follow up with improved contraception defined as 1) no contraception changed to some form of contraception, 2) barrier methods changed to combined hormonal contraception/ IUD/contraceptive implant/tubal ligation, or 3) combined hormonal method to an IUD/contraceptive implant/tubal ligation.
Interventions
- BEHAVIORAL Baseline Questionnaire
- BEHAVIORAL EMR Referral
- BEHAVIORAL CTIS Counseling
- BEHAVIORAL Contraception Provision Appointment
- BEHAVIORAL 3 Month Follow Up Questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2012-04 |
| Est. Completion | 2013-10 |
| Phase | NA |
What the finished NCT02293213 record still lists
NCT02293213 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 33 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 5 interventions - of which Baseline Questionnaire is the first listed.
NCT02293213 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02293213 about?
NCT02293213 is a clinical study titled "EMR Referrals for Teratogen and Contraceptive Counseling for Category D or X Medication Users: RCT". Investigators propose a randomized controlled trial of women taking category D or X medications seen in family medicine, internal medicine or in the Coumadin Clinic. Women in the intervention group will receive an electronic medical record referral for teratogen counseling and contraceptive counseli...
What is the current status of trial NCT02293213?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2012-04. Estimated completion is 2013-10.
What interventions are being tested in trial NCT02293213?
The interventions under investigation include: Baseline Questionnaire (BEHAVIORAL), EMR Referral (BEHAVIORAL), CTIS Counseling (BEHAVIORAL), Contraception Provision Appointment (BEHAVIORAL), 3 Month Follow Up Questionnaire (BEHAVIORAL).
Who is sponsoring clinical trial NCT02293213?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02293213's enrollment target sits among peer trials
33 1574th of 2000 higher than 423 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia